SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported)
June 30, 1998
EXTEN INDUSTRIES, INC.
(Exact name or registrant as specified in its charter)
Delaware 0-16354 52-1412493
(State or other (Commission (I.R.S. Employer
jurisdiction of file number) Identification No.)
incorporation
or organization)
9625 Black Mountain Road, Suite 218, San Diego, California 62126
(Address of principal executive offices) (Zip Code)
9625 Black Mountain Road, Suite 218, San Diego, California 62126
(Mailing Address) (Zip Code)
Registrant's telephone number, including area code:
(619) 578-9784
Item 5. OTHER EVENTS
The Registrant has promoted Mr. Jerry Simek to President and COO.
Mr. Simek was promoted to president and chief operating
officer at Exten's June board meeting. W. Gerald Newmin will
remain as chairman and chief executive officer of Exten
Industries Inc.
A copy of the June 30, 1998 Press Release is attached.
Item 7. Financial Statements and Exhibits.
99.1 Press Release.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of
the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the under-
signed, thereunto duly authorized.
EXTEN INDUSTRIES, INC.
(Registrant)
By: /s/ W. GERALD NEWMIN
-----------------------------
Chairman, Chief Executive Officer
and President
Date: June 30, 1998
________________________________________________________________
FOR FURTHER INFORMATION:
- -----------------------------------------------------------------
NEWS
FOR IMMEDIATE RELEASE:
June 30, 1998 CONTACTS:
At Exten Industries, Inc.
W. Gerald Newmin, President
Barbara Corbett,
Marketing Mgr.
(619) 578-9784
After hours:
(619) 455-7205, 423-3737
Exten Industries Inc. Promotes Simek to President and COO
SAN DIEGO--(BW HealthWire)--June 30, 1998--Jerry G. Simek was
promoted to president and chief operating officer at Exten's
June board meeting. W. Gerald Newmin will remain as chairman
and chief executive officer of Exten Industries Inc. ``The growth
of the company and increased activity level as the company pursues
acquisition opportunities and funding as well as the preclinical
trials at Loyola University Medical Center, require additional
management support,'' Newmin explained.
Simek stated, ``I look forward to my expanded role and I will
continue to focus on the company's acquisition program.''
Simek, president of JGS Management Group since 1984, specializes
in strategic planning, financial management, business/corporate
development and international business. He has successfully
directed and implemented several company reorganizations,
refinancing programs, company turnarounds, plus market development
as well as company acquisition and divestiture programs.
Simek has over three decades of multinational management experience
in the medical, energy, electronics and aerospace industries. He
has held key management positions with major medical companies such
as Baxter and Johnson & Johnson. In addition he has served as a
director and/or management advisor for several other public and
private companies worldwide. Simek, who lives in La Jolla, Calif.,
has a bachelor's of science from Illinois Institute of Technology
and an MBA from Pepperdine University.
Exten Industries Inc. is a publicly traded company listed on the Over the
Counter Bulletin Board (symbol EXTI). Through its subsidiary, Xenogenics,
the company is developing a bio-artificial liver device to perform the
equivalent of kidney dialysis for liver patients.With the worldwide
incidence of liver diseases, the device could fill a critical need.
The device is currently in the early phases of testing at Loyola
University Medical Center in Chicago. Headquarters are at 9625 Black
Mountain Rd., Ste. 218, San Diego, CA 92126-4564.
For more information call the contacts listed or e-mail at
[email protected]. Exten's website address is http://www.exten.com.
This news release contains forward-looking statements based on the
company's expectations that are subject to a number of risks and
uncertainties which can be beyond the company's control.
